Sugar amides and mixtures thereof
US-2024409523-A1 · Dec 12, 2024 · US
US11471394B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11471394-B2 |
| Application number | US-202016884958-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 27, 2020 |
| Priority date | Mar 15, 2013 |
| Publication date | Oct 18, 2022 |
| Grant date | Oct 18, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are oral care compositions comprising a deoxy sugar antimetabolite and methods of inhibiting microbial biofilm formation and/or degrading a microbial biofilm in a subject.
Opening claim text (preview).
The invention claimed is: 1. A method of inhibiting microbial biofilm formation and/or degrading a microbial biofilm in the oral cavity of a subject comprising administering to the subject an oral care composition comprising a deoxy sugar antimetabolite with no additional antibacterial agent and an orally acceptable carrier, wherein the deoxy sugar antimetabolite is present in the composition at a concentration of from 0.005% to 0.7% based on the total weight of the composition, wherein bacteria is decreased by less than 5% and biofilm is inhibited by at least 25%, and wherein the deoxy sugar antimetabolite is selected from the group consisting of 6-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, 2-amino-2-deoxy-D-mannosamine, and mixtures thereof. 2. The method of claim 1 , wherein the deoxy sugar antimetabolite is selected from the group consisting of 6-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and mixtures thereof. 3. The method of claim 1 , wherein the deoxy sugar antimetabolite is 2-amino-2-deoxy-D-mannosamine. 4. The method of claim 1 , wherein the biofilm efficiency is at least 1000%. 5. The method according to claim 1 , wherein the method comprises treats a disease condition of the oral cavity by inhibiting microbial biofilm formation and/or degrading a microbial biofilm in the oral cavity which is selected from the group consisting of dental plaque, tooth decay, periodontal disease and gingivitis. 6. The method according to claim 1 , wherein the biofilm is formed from one or more species of bacteria selected from Actinomyces viscosus, Actinomyces naeslundii, Lactobacillus casei, Streptococcus oralis, Fusobacterium nucleatum and Veillonella parvula , and Porphyromonas gingivalis. 7. The method of claim 1 , wherein the deoxy sugar antimetabolite is 6-deoxy-D-glucose. 8. The method of claim 1 , wherein the deoxy sugar antimetabolite is 2-fluoro-2-deoxy-D-glucose. 9. The method of claim 1 , wherein the deoxy sugar antimetabolite is present in the composition at a concentration of from 0.005% to 0.5% based on the total weight of the composition. 10. The method of claim 1 , wherein the deoxy sugar antimetabolite is present in the composition at a concentration of from 0.008% to 0.3% based on the total weight of the composition.
Related publications grouped by family.
Answers are generated from the same data shown on this page.